CVS HEALTH CORP (1CVS.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1CVS - US1266501006 - Common Stock
68.4 EUR
-0.1 (-0.15%)
Overall 1CVS gets a fundamental rating of 4 out of 10. We evaluated 1CVS against 30 industry peers in the Health Care Providers & Services industry. 1CVS may be in some trouble as it scores bad on both profitability and health. 1CVS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- 1CVS had positive earnings in the past year.
- In the past year 1CVS had a positive cash flow from operations.
- Each year in the past 5 years 1CVS has been profitable.
- In the past 5 years 1CVS always reported a positive cash flow from operatings.
1.2 Ratios
- 1CVS has a Return On Assets of 0.18%. This is in the lower half of the industry: 1CVS underperforms 70.00% of its industry peers.
- The Return On Equity of 1CVS (0.64%) is worse than 73.33% of its industry peers.
- 1CVS has a Return On Invested Capital (4.90%) which is in line with its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1CVS is in line with the industry average of 6.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROIC | 4.9% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
1.3 Margins
- 1CVS's Profit Margin of 0.12% is on the low side compared to the rest of the industry. 1CVS is outperformed by 70.00% of its industry peers.
- In the last couple of years the Profit Margin of 1CVS has declined.
- 1CVS's Operating Margin of 2.73% is on the low side compared to the rest of the industry. 1CVS is outperformed by 70.00% of its industry peers.
- 1CVS's Operating Margin has declined in the last couple of years.
- 1CVS has a worse Gross Margin (13.88%) than 63.33% of its industry peers.
- In the last couple of years the Gross Margin of 1CVS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% |
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CVS is destroying value.
- Compared to 1 year ago, 1CVS has less shares outstanding
- The number of shares outstanding for 1CVS has been reduced compared to 5 years ago.
- Compared to 1 year ago, 1CVS has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.27 indicates that 1CVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.27, 1CVS is in the better half of the industry, outperforming 63.33% of the companies in the same industry.
- The Debt to FCF ratio of 1CVS is 10.46, which is on the high side as it means it would take 1CVS, 10.46 years of fcf income to pay off all of its debts.
- 1CVS has a Debt to FCF ratio of 10.46. This is comparable to the rest of the industry: 1CVS outperforms 46.67% of its industry peers.
- 1CVS has a Debt/Equity ratio of 0.85. This is a neutral value indicating 1CVS is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.85, 1CVS is in line with its industry, outperforming 53.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Altman-Z | 2.27 |
ROIC/WACC0.61
WACC8.06%
2.3 Liquidity
- 1CVS has a Current Ratio of 0.83. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Current ratio of 1CVS (0.83) is worse than 60.00% of its industry peers.
- 1CVS has a Quick Ratio of 0.83. This is a bad value and indicates that 1CVS is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.63, 1CVS is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
- The Earnings Per Share has been growing slightly by 7.87% over the past year.
- Measured over the past years, 1CVS shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.20% on average per year.
- The Revenue has been growing slightly by 6.82% in the past year.
- The Revenue has been growing slightly by 7.74% on average over the past years.
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
3.2 Future
- Based on estimates for the next years, 1CVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.81% on average per year.
- 1CVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.65% yearly.
EPS Next Y23.97%
EPS Next 2Y15.58%
EPS Next 3Y15.14%
EPS Next 5Y13.81%
Revenue Next Year7.58%
Revenue Next 2Y5.09%
Revenue Next 3Y5.2%
Revenue Next 5Y4.65%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- 1CVS is valuated reasonably with a Price/Earnings ratio of 11.61.
- Based on the Price/Earnings ratio, 1CVS is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 26.94, 1CVS is valued rather cheaply.
- The Price/Forward Earnings ratio is 10.99, which indicates a very decent valuation of 1CVS.
- 76.67% of the companies in the same industry are more expensive than 1CVS, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.94, 1CVS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.61 | ||
| Fwd PE | 10.99 |
4.2 Price Multiples
- 1CVS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.05 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- 1CVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as 1CVS's earnings are expected to grow with 15.14% in the coming years.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y15.58%
EPS Next 3Y15.14%
5. Dividend
5.1 Amount
- 1CVS has a Yearly Dividend Yield of 3.27%.
- 1CVS's Dividend Yield is rather good when compared to the industry average which is at 1.73. 1CVS pays more dividend than 93.33% of the companies in the same industry.
- 1CVS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.27% |
5.2 History
- The dividend of 1CVS has a limited annual growth rate of 5.72%.
Dividend Growth(5Y)5.72%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
- 722.81% of the earnings are spent on dividend by 1CVS. This is not a sustainable payout ratio.
- 1CVS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP722.81%
EPS Next 2Y15.58%
EPS Next 3Y15.14%
BIT:1CVS (1/16/2026, 7:00:00 PM)
68.4
-0.1 (-0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners89.6%
Inst Owner ChangeN/A
Ins Owners0.99%
Ins Owner ChangeN/A
Market Cap86.83B
Revenue(TTM)394.08B
Net Income(TTM)469.00M
Analysts80
Price Target80.9 (18.27%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.27% |
Yearly Dividend2.28
Dividend Growth(5Y)5.72%
DP722.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.34%
Min EPS beat(2)15.69%
Max EPS beat(2)22.99%
EPS beat(4)4
Avg EPS beat(4)24.17%
Min EPS beat(4)15.69%
Max EPS beat(4)30.76%
EPS beat(8)6
Avg EPS beat(8)6.87%
EPS beat(12)10
Avg EPS beat(12)5.67%
EPS beat(16)14
Avg EPS beat(16)5.3%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)3.04%
Max Revenue beat(2)3.64%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-0.46%
Max Revenue beat(4)3.64%
Revenue beat(8)5
Avg Revenue beat(8)0.97%
Revenue beat(12)9
Avg Revenue beat(12)1.97%
Revenue beat(16)13
Avg Revenue beat(16)2.12%
PT rev (1m)16.14%
PT rev (3m)15.66%
EPS NQ rev (1m)0.21%
EPS NQ rev (3m)5.57%
EPS NY rev (1m)0.81%
EPS NY rev (3m)4.53%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)1.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.61 | ||
| Fwd PE | 10.99 | ||
| P/S | 0.26 | ||
| P/FCF | 16.05 | ||
| P/OCF | 11.09 | ||
| P/B | 1.38 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)5.89
EY8.61%
EPS(NY)6.22
Fwd EY9.1%
FCF(TTM)4.26
FCFY6.23%
OCF(TTM)6.17
OCFY9.02%
SpS266.91
BVpS49.39
TBVpS-26.1
PEG (NY)0.48
PEG (5Y)N/A
Graham Number80.91
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.18% | ||
| ROE | 0.64% | ||
| ROCE | 6.61% | ||
| ROIC | 4.9% | ||
| ROICexc | 5.26% | ||
| ROICexgc | 19.51% | ||
| OM | 2.73% | ||
| PM (TTM) | 0.12% | ||
| GM | 13.88% | ||
| FCFM | 1.6% |
ROA(3y)2.35%
ROA(5y)2.72%
ROE(3y)7.68%
ROE(5y)8.81%
ROIC(3y)6.22%
ROIC(5y)6.35%
ROICexc(3y)6.76%
ROICexc(5y)6.87%
ROICexgc(3y)25.87%
ROICexgc(5y)25.07%
ROCE(3y)8.35%
ROCE(5y)8.51%
ROICexgc growth 3Y-10.65%
ROICexgc growth 5Y-1.15%
ROICexc growth 3Y-14.28%
ROICexc growth 5Y-4.08%
OM growth 3Y-19.77%
OM growth 5Y-11.12%
PM growth 3Y-23.26%
PM growth 5Y-13.69%
GM growth 3Y-8.24%
GM growth 5Y-4.91%
F-Score6
Asset Turnover1.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 10.46 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.71% | ||
| Interest Coverage | -3.53 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 1341.79% | ||
| Current Ratio | 0.83 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 2.27 |
F-Score6
WACC8.06%
ROIC/WACC0.61
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.84%
Profit Quality(3y)191.23%
Profit Quality(5y)191.5%
High Growth Momentum
Growth
EPS 1Y (TTM)7.87%
EPS 3Y-13.62%
EPS 5Y-5.2%
EPS Q2Q%46.79%
EPS Next Y23.97%
EPS Next 2Y15.58%
EPS Next 3Y15.14%
EPS Next 5Y13.81%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y8.47%
Revenue growth 5Y7.74%
Sales Q2Q%7.8%
Revenue Next Year7.58%
Revenue Next 2Y5.09%
Revenue Next 3Y5.2%
Revenue Next 5Y4.65%
EBIT growth 1Y-3.81%
EBIT growth 3Y-12.98%
EBIT growth 5Y-4.24%
EBIT Next Year46.72%
EBIT Next 3Y19.51%
EBIT Next 5Y17.54%
FCF growth 1Y-44.32%
FCF growth 3Y-26.21%
FCF growth 5Y-9.45%
OCF growth 1Y-35.44%
OCF growth 3Y-20.7%
OCF growth 5Y-6.65%
CVS HEALTH CORP / 1CVS.MI FAQ
What is the fundamental rating for 1CVS stock?
ChartMill assigns a fundamental rating of 4 / 10 to 1CVS.MI.
What is the valuation status of CVS HEALTH CORP (1CVS.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to CVS HEALTH CORP (1CVS.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for CVS HEALTH CORP?
CVS HEALTH CORP (1CVS.MI) has a profitability rating of 3 / 10.
How financially healthy is CVS HEALTH CORP?
The financial health rating of CVS HEALTH CORP (1CVS.MI) is 3 / 10.
Is the dividend of CVS HEALTH CORP sustainable?
The dividend rating of CVS HEALTH CORP (1CVS.MI) is 6 / 10 and the dividend payout ratio is 722.81%.